Results: 1-15 |
Results: 15

Authors: Vey, N Balatzentko, G LaFage, M Sainty, D Bouabdallah, R Chabannon, C Blaise, D Gastaut, JA Gabert, J
Citation: N. Vey et al., Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia, LEUK LYMPH, 42(5), 2001, pp. 945-952

Authors: Vey, N Camerlo, J Xerri, L Petit, N Dermeche, S Maraninchi, D
Citation: N. Vey et al., Simultaneous occurrence of Kaposi's Sarcoma and chronic myelogenous leukemia, LEUK LYMPH, 41(3-4), 2001, pp. 425

Authors: Mohty, M Faucher, C Chabannon, C Vey, N Stoppa, AM Ladaique, P Novakovitch, G Olivero, S Bouabdallah, R Gastaut, JA Maraninchi, D Blaise, D
Citation: M. Mohty et al., CD34(+) immunoselected cells for poor graft function following allogeneic BMT, CYTOTHERAPY, 2(5), 2000, pp. 367-370

Authors: Vey, N Giles, FJ Kantarjian, H Smith, TL Beran, M Jeha, S
Citation: N. Vey et al., The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia, CLIN CANC R, 6(2), 2000, pp. 731-736

Authors: Mohty, M Faucher, C Vey, N Stoppa, AM Viret, F Chabbert, I Chabannon, C Bouabdallah, R Ladaique, P Collet, L Zandotti, C Maraninchi, D Baise, D
Citation: M. Mohty et al., High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation, BONE MAR TR, 26(3), 2000, pp. 251-255

Authors: Gravis, G Viens, P Vey, N Blaise, D Stoppa, AM Olive, D Maraninchi, D
Citation: G. Gravis et al., Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers, ANTICANC R, 20(5C), 2000, pp. 3987-3991

Authors: Blaise, D Faucher, C Vey, N Caraux, J Maraninchi, D Chabannon, C
Citation: D. Blaise et al., Rescue of haemopoiesis by a combination of growth factors including stem-cell factor, LANCET, 356(9238), 2000, pp. 1325-1326

Authors: Granel, B Serratrice, J Swiader, L Horshowski, N Blaise, D Vey, N Metras, D Habib, G Disdier, P Weiller, PJ
Citation: B. Granel et al., Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma - A case report, CANCER, 89(10), 2000, pp. 2138-2143

Authors: Vey, N Blaise, D Lafage, M Olive, D Viens, P Baume, D Camerlo, J Stoppa, AM Gabus, R Brandely, M Hercend, T Maraninchi, D
Citation: N. Vey et al., Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients, J IMMUNOTH, 22(2), 1999, pp. 175-181

Authors: Viret, F Blaise, D Bouabdallah, R Stoppa, AM Novakovitch, G Faucher, C Vey, N Camerlo, J Oziel-Taieb, S Ladaique, P Gastaut, JA Maraninchi, D Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11

Authors: Vey, N Kantarjian, H Tran, H Beran, M O'Brien, S Bivins, C Giles, F Cortes, J Cheson, B Arbuck, S Estey, E
Citation: N. Vey et al., Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia, ANN ONCOL, 10(5), 1999, pp. 577-583

Authors: Beran, M Estey, E O'Brien, S Cortes, J Koller, CA Giles, FJ Kornblau, S Andreeff, M Vey, N Pierce, SR Hayes, K Wong, GC Keating, M Kantarjian, H
Citation: M. Beran et al., Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia, J CL ONCOL, 17(9), 1999, pp. 2819-2830

Authors: Vey, N Kantarjian, H Beran, M O'Brien, S Cortes, J Koller, C Estey, E
Citation: N. Vey et al., Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study, INV NEW DR, 17(1), 1999, pp. 89-95

Authors: Vey, N Keating, M Giles, F Cortes, J Beran, M Estey, E
Citation: N. Vey et al., Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapy, BLOOD, 93(9), 1999, pp. 3149-3150

Authors: Maraninchi, D Vey, N Viens, P Stoppa, AM Archimbaud, E Attal, M Baume, D Bouabdallah, R Demeoq, F Fleury, J Michallet, M Olive, D Reiffers, J Sainty, D Tabilio, A Tiberghien, P Brandely, M Hercend, T Blaise, D
Citation: D. Maraninchi et al., A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 343-349
Risultati: 1-15 |